CHARLES RIV LAB INT
CHARLES RIV LAB INT operates in Diversified Metals & Mining.
CHARLES RIV LAB INT (RV6) - Total Liabilities
Latest total liabilities as of September 2024: €4.18 Billion EUR
Based on the latest financial reports, CHARLES RIV LAB INT (RV6) has total liabilities worth €4.18 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CHARLES RIV LAB INT - Total Liabilities Trend (2016–2023)
This chart illustrates how CHARLES RIV LAB INT's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CHARLES RIV LAB INT Competitors by Total Liabilities
The table below lists competitors of CHARLES RIV LAB INT ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fifax Abp
HE:FIFAX
|
Finland | €9.88 Million |
|
Betonjaya Manunggal Tbk
JK:BTON
|
Indonesia | Rp151.24 Billion |
|
Cutera Inc
NASDAQ:CUTR
|
USA | $487.29 Million |
|
Nevada Sunrise Gold Corporation
PINK:NVSGF
|
USA | $129.67K |
|
Enertime SAS
PA:ALENE
|
France | €9.26 Million |
|
CDN Maverick Capital Corp
OTCQB:AXVEF
|
USA | $359.15K |
|
Chiangmai Rimdoi Public Company Limited
BK:CRD
|
Thailand | ฿530.03 Million |
|
Spring Valley Acquisition Corp. II Rights
NASDAQ:SVIIR
|
USA | $5.87 Million |
Liability Composition Analysis (2016–2023)
This chart breaks down CHARLES RIV LAB INT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CHARLES RIV LAB INT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CHARLES RIV LAB INT (2016–2023)
The table below shows the annual total liabilities of CHARLES RIV LAB INT from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €4.54 Billion | -0.94% |
| 2022-12-31 | €4.58 Billion | +3.32% |
| 2021-12-31 | €4.43 Billion | +32.42% |
| 2020-12-31 | €3.35 Billion | +9.56% |
| 2019-12-31 | €3.05 Billion | +20.46% |
| 2018-12-31 | €2.54 Billion | +34.72% |
| 2017-12-31 | €1.88 Billion | +0.53% |
| 2016-12-31 | €1.87 Billion | -- |